Alnylam Pharmaceuticals shares owned by BlackRock
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.3B | 9.5M | 243.00 |
| 2024-03-31 | $1.3B | 9.0M | 149.45 |
| 2023-09-30 | $1.5B | 8.4M | 177.10 |
| 2023-06-30 | $1.6B | 8.4M | 189.94 |
| 2023-03-31 | $1.7B | 8.5M | 200.32 |
| 2022-12-31 | $2.0B | 8.5M | 237.65 |
| 2022-06-30 | $1.1B | 7.7M | 145.85 |
| 2021-06-30 | $1.5B | 8.7M | 169.52 |
| 2021-03-31 | $1.3B | 9.0M | 141.19 |
| 2020-12-31 | $1.1B | 8.7M | 129.97 |
| 2020-09-30 | $1.3B | 8.9M | 145.60 |
| 2020-03-31 | $933M | 8.6M | 108.85 |
| 2019-12-31 | $925M | 8.0M | 115.17 |
| 2019-09-30 | $571M | 7.1M | 80.42 |
| 2019-06-30 | $474M | 6.5M | 72.56 |
| 2019-03-31 | $601M | 6.4M | 93.45 |
| 2018-12-31 | $448M | 6.1M | 72.91 |
| 2018-09-30 | $533M | 6.1M | 87.52 |
| 2018-06-30 | $605M | 6.1M | 98.49 |
| 2018-03-31 | $855M | 7.2M | 119.10 |
| 2017-09-30 | $718M | 6.1M | 117.49 |
| 2016-12-31 | $509k | 14k | 37.39 |
| 2016-09-30 | $5.0M | 74k | 67.79 |
| 2016-06-30 | $4.8M | 87k | 55.49 |
| 2016-03-31 | $4.4M | 70k | 62.77 |
| 2015-12-31 | $5.1M | 54k | 94.12 |
| 2015-09-30 | $2.6M | 33k | 80.43 |
| 2015-06-30 | $5.7M | 48k | 119.88 |
| 2015-03-31 | $202k | 1.9k | 105.11 |
| 2014-12-31 | $176k | 1.8k | 96.10 |
| 2014-09-30 | $147k | 1.9k | 78.08 |
| 2014-06-30 | $116k | 1.8k | 63.06 |
| 2014-03-31 | $116k | 1.8k | 66.07 |
| 2013-12-31 | $111k | 1.8k | 63.06 |
| 2013-09-30 | $4.6M | 71k | 64.02 |
| 2013-06-30 | $2.5M | 81k | 31.00 |